Plasma membrane ion channels and transporters

Plasma membrane ion channels and transporters are a diverse group of integral membrane proteins that facilitate the movement of ions and small molecules across the cell's lipid bilayer [1]. These proteins are essential for maintaining cellular homeostasis, regulating osmotic pressure, and generating electrical signals in excitable tissues like nerves and muscles [2]. Ion channels typically allow for the rapid, passive flow of ions down their electrochemical gradients, while transporters (including pumps and carriers) often move substances against their gradients using energy or coupled transport [1, 4]. Due to their critical roles in physiology, these proteins are major therapeutic targets for a wide range of conditions, including cardiovascular diseases, neurological disorders, and metabolic syndromes [2, 3]. Drugs targeting these proteins often act as blockers, activators, or modulators to restore normal physiological function [3]. For example, sodium channel blockers are used as local anesthetics and antiarrhythmics, while solute carrier inhibitors are used to treat depression and hypertension [2, 3]. However, the high degree of homology between different channel and transporter subtypes can lead to challenges in achieving drug selectivity and avoiding off-target side effects [2]. Understanding the structural biology of these proteins is crucial for the development of next-generation therapies with improved safety profiles [1, 2].

Other names

Membrane transport proteinsIonophoresSolute carriersABC transportersP-type ATPases

Drugs targeting these proteins typically function through pore blockade, allosteric modulation, competitive inhibition of substrate binding sites, or by altering the gating kinetics of the channel [1, 3].